Literature DB >> 23318449

The histone acetyltransferase component TRRAP is targeted for destruction during the cell cycle.

G Ichim1, M Mola1, M G Finkbeiner1, M-P Cros1, Z Herceg1, H Hernandez-Vargas1.   

Abstract

Chromosomes are dynamic structures that must be reversibly condensed and unfolded to accommodate mitotic division and chromosome segregation. Histone modifications are involved in the striking chromatin reconfiguration taking place during mitosis. However, the mechanisms that regulate activity and function of histone-modifying factors as cells enter and exit mitosis are poorly understood. Here, we show that the anaphase-promoting complex or cyclosome (APC/C) is involved in the mitotic turnover of TRRAP (TRansformation/tRanscription domain-Associated Protein), a common component of histone acetyltransferase (HAT) complexes, and that the pre-mitotic degradation of TRRAP is mediated by the APC/C ubiquitin ligase activators Cdc20 and Cdh1. Ectopic expression of both Cdh1 and Cdc20 reduced the levels of coexpressed TRRAP protein and induced its ubiquitination. TRRAP overexpression or stabilization induces multiple mitotic defects, including lagging chromosomes, chromosome bridges and multipolar spindles. In addition, lack of sister chromatid cohesion and impaired chromosome condensation were found after TRRAP overexpression or stabilization. By using a truncated form of TRRAP, we show that mitotic delay is associated with a global histone H4 hyperacetylation induced by TRRAP overexpression. These results demonstrate that the chromatin modifier TRRAP is targeted for destruction in a cell cycle-dependent fashion. They also suggest that degradation of TRRAP by the APC/C is necessary for a proper condensation of chromatin and proper chromosome segregation. Chromatin compaction mediated by histone modifiers may represent a fundamental arm for APC/C orchestration of the mitotic machinery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318449     DOI: 10.1038/onc.2012.570

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis.

Authors:  Jinfang Zhang; Lixin Wan; Xiangpeng Dai; Yi Sun; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-02-22

Review 2.  Targeting Cdc20 as a novel cancer therapeutic strategy.

Authors:  Lixia Wang; Jinfang Zhang; Lixin Wan; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Pharmacol Ther       Date:  2015-04-04       Impact factor: 12.310

3.  Tissue-specific inactivation of HAT cofactor TRRAP reveals its essential role in B cells.

Authors:  Claire Leduc; Guillaume Chemin; Nadine Puget; Carla Sawan; Mohammed Moutahir; Zdenko Herceg; Ahmed Amine Khamlichi
Journal:  Cell Cycle       Date:  2014-03-18       Impact factor: 4.534

4.  Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G1/S phase transition.

Authors:  Reyad A Elbarbary; Keita Miyoshi; Jason R Myers; Peicheng Du; John M Ashton; Bin Tian; Lynne E Maquat
Journal:  Science       Date:  2017-05-26       Impact factor: 47.728

5.  Histones: Controlling Tumor Signaling Circuitry.

Authors:  Manoela D Martins; Rogerio M Castilho
Journal:  J Carcinog Mutagen       Date:  2013-07-29

6.  In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.

Authors:  Peter A van Dam; Pieter-Jan H H van Dam; Christian Rolfo; Marco Giallombardo; Christophe van Berckelaer; Xuan Bich Trinh; Sevilay Altintas; Manon Huizing; Kostas Papadimitriou; Wiebren A A Tjalma; Steven van Laere
Journal:  Oncotarget       Date:  2016-01-19

7.  TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells.

Authors:  Kyung Taek Kang; Yang Woo Kwon; Dae Kyoung Kim; Su In Lee; Ki-Hyung Kim; Dong-Soo Suh; Jae Ho Kim
Journal:  BMB Rep       Date:  2018-10       Impact factor: 4.778

8.  A novel strategy to block mitotic progression for targeted therapy.

Authors:  Junlong Jack Chi; Hongchun Li; Zhuan Zhou; Javier Izquierdo-Ferrer; Yifan Xue; Cindy M Wavelet; Gary E Schiltz; Bin Zhang; Massimo Cristofanilli; Xinghua Lu; Ivet Bahar; Yong Wan
Journal:  EBioMedicine       Date:  2019-10-25       Impact factor: 8.143

Review 9.  The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.

Authors:  Cordell VanGenderen; Troy Anthony Alan Harkness; Terra Gayle Arnason
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

10.  Estrogen receptor alpha (ERα)-mediated coregulator binding and gene expression discriminates the toxic ERα agonist diethylstilbestrol (DES) from the endogenous ERα agonist 17β-estradiol (E2).

Authors:  Aziza Hussein Bakheit Adam; Laura H J de Haan; Ignacio Miro Estruch; Guido J E J Hooiveld; Jochem Louisse; Ivonne M C M Rietjens
Journal:  Cell Biol Toxicol       Date:  2020-02-22       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.